NO983920L - Isoksaszolderivater - Google Patents

Isoksaszolderivater

Info

Publication number
NO983920L
NO983920L NO983920A NO983920A NO983920L NO 983920 L NO983920 L NO 983920L NO 983920 A NO983920 A NO 983920A NO 983920 A NO983920 A NO 983920A NO 983920 L NO983920 L NO 983920L
Authority
NO
Norway
Prior art keywords
optionally substituted
alkanoyl
cycloalkenyl
alkoxycarbonyl
alkynyl
Prior art date
Application number
NO983920A
Other languages
English (en)
Norwegian (no)
Other versions
NO983920D0 (no
Inventor
Koichi Kojima
Junichi Sakai
Naozumi Samata
Masao Kozuka
Kenji Yoshimi
Tsugio Kaneko
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO983920D0 publication Critical patent/NO983920D0/no
Publication of NO983920L publication Critical patent/NO983920L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO983920A 1996-02-27 1998-08-26 Isoksaszolderivater NO983920L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3981996 1996-02-27
PCT/JP1997/000583 WO1997031906A1 (fr) 1996-02-27 1997-02-27 Derives d'isoxazole

Publications (2)

Publication Number Publication Date
NO983920D0 NO983920D0 (no) 1998-08-26
NO983920L true NO983920L (no) 1998-10-27

Family

ID=12563591

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983920A NO983920L (no) 1996-02-27 1998-08-26 Isoksaszolderivater

Country Status (11)

Country Link
US (1) US6005116A (zh)
EP (1) EP0885891A4 (zh)
KR (1) KR19990087339A (zh)
CN (1) CN1216986A (zh)
AU (1) AU711927B2 (zh)
CA (1) CA2247439A1 (zh)
CZ (1) CZ272598A3 (zh)
HU (1) HUP9900400A3 (zh)
NO (1) NO983920L (zh)
RU (1) RU2165415C2 (zh)
WO (1) WO1997031906A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221854B1 (en) * 1996-03-05 2001-04-24 Orquest, Inc. Method of promoting bone growth with hyaluronic acid and growth factors
KR20040022238A (ko) * 2001-08-09 2004-03-11 오노 야꾸힝 고교 가부시키가이샤 카르복실산 유도체 화합물 및 그 화합물을 유효성분으로서 함유하는 약제
KR20120007079A (ko) * 2003-10-15 2012-01-19 프로비오드룩 아게 글루타미닐 및 글루타메이트 사이클라제 이펙터의 용도
AU2005245411B2 (en) * 2004-05-14 2009-04-23 Irm Llc Compounds and compositions as PPAR modulators
KR20080047959A (ko) * 2006-11-27 2008-05-30 주식회사 엠디바이오알파 비만, 당뇨, 대사성 질환, 퇴행성 질환 및 미토콘드리아이상 질환의 치료 또는 예방을 위한 나프토퀴논계 약제조성물
CA2668713C (en) 2006-12-01 2015-09-08 Banyu Pharmaceutical Co., Ltd. Novel phenyl-isoxazol-3-ol derivative
KR101405823B1 (ko) * 2007-12-24 2014-06-12 주식회사 케이티앤지생명과학 녹내장의 치료 및 예방을 위한 약제 조성물
KR20090071829A (ko) * 2007-12-28 2009-07-02 주식회사 머젠스 신장질환의 치료 및 예방을 위한 약제 조성물
PE20110843A1 (es) 2008-09-22 2011-12-08 Cayman Chem Co Derivados de 5-(1h-imidazol-5-il)-2-fenilpirimidina, como inhibidores de prostaglandina d sintasa hematopoyetica
EP2495238A4 (en) 2009-10-30 2013-04-24 Mochida Pharm Co Ltd NEW 3-HYDROXY-5-ARYLISOXAZOLE DERIVATIVE
MX2012007474A (es) 2009-12-25 2012-08-01 Mochida Pharm Co Ltd Derivados de 3-hidroxi-5-arilisotiazol novedosos.
MX2013012520A (es) 2011-04-27 2014-02-03 Mochida Pharm Co Ltd Derivado novedoso de 1-oxido de 3-hidroxi isotiazol.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2585374B2 (ja) * 1988-05-31 1997-02-26 三共株式会社 イソオキサゾリン−3−オン関連化合物およびその用途
JPS59216881A (ja) * 1983-05-23 1984-12-06 Sankyo Co Ltd 3−ヒドロキシイソオキサゾ−ル誘導体の製造法
JPS63152367A (ja) * 1986-08-25 1988-06-24 Shionogi & Co Ltd 3―パーフルオロアルキル―5―置換オキシイソオキサゾール誘導体およびそれを有効成分として含有する除草剤
US5321037A (en) * 1986-12-26 1994-06-14 Sankyo Company, Limited Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants
IE62276B1 (en) * 1988-03-30 1995-01-25 Sankyo Co "New isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants"
JP2786684B2 (ja) * 1989-08-22 1998-08-13 三共株式会社 イソオキサゾール化合物を有効成分とする抗うつ剤
US5116839A (en) * 1989-06-26 1992-05-26 Sankyo Company, Limited Use of isoxazolin-3-one derivatives as antidepressants
JP2786683B2 (ja) * 1989-08-15 1998-08-13 三共株式会社 グリコール誘導体およびその用途
IE65997B1 (en) * 1990-05-11 1995-11-29 Sankyo Co Piperidyloxy- and quinuclidinyloxy- isoxazole derivatives their preparation and their therapeutic use
US5494908A (en) * 1992-11-23 1996-02-27 Hoechst-Roussel Pharmaceutical Incorporated Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds
US5547967A (en) * 1993-12-08 1996-08-20 Kali-Chemie Pharma Gmbh (Phenylalkylaminoalkyloxy)-heteroaryl-compounds, processes and intermediates for their production and pharmaceutical compositions containing them
WO1996006837A1 (fr) * 1994-08-30 1996-03-07 Sankyo Company, Limited Isoxazoles

Also Published As

Publication number Publication date
EP0885891A4 (en) 2001-02-21
HUP9900400A2 (hu) 1999-05-28
US6005116A (en) 1999-12-21
NO983920D0 (no) 1998-08-26
EP0885891A1 (en) 1998-12-23
AU711927B2 (en) 1999-10-21
WO1997031906A1 (fr) 1997-09-04
RU2165415C2 (ru) 2001-04-20
CN1216986A (zh) 1999-05-19
HUP9900400A3 (en) 2001-06-28
CZ272598A3 (cs) 1999-01-13
AU1812297A (en) 1997-09-16
KR19990087339A (ko) 1999-12-27
CA2247439A1 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
NO20050870L (no) Fosfodiesterase 4-inhibitorer, inkludert N-substituerte anilin- og difenylaminanaloger
ATE396993T1 (de) Tetrahydropyranyl-cyclopentyl- tetrahydropyridopyridin-modulatoren der chemokin- rezeptor-aktivität
YU57603A (sh) Inhibitori fosfodiesteraze 4
NO20062099L (no) Synergistiske fungicide aktive substanskombinasjoner
NO983920L (no) Isoksaszolderivater
NO20003233D0 (no) 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler
ATE318267T1 (de) Einige alkylendiamin-substituierte heterocyclen
MY107740A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
PL341044A1 (en) Derivatives of orthoantranilic amide as anticoagulants
SG169900A1 (en) 4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors
ATE444065T1 (de) 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidon-deriva e als pde-4-hemmer zur behandlung von neurologischen syndromen
YU41801A (sh) Derivati fenilglicina
TW200602322A (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
NO20062633L (no) Pyrazolderivater som proteinkinasemodulatorer
ES2196396T3 (es) Compuestos heteroaromaticos de 5 miembros conteniendo oxigeno o azufre como inhibidores del factor xa.
HUP0100388A2 (hu) Készítmények és eljárások csontritkulás kezelésére és a koleszterinszint csökkentésére
ATE290382T1 (de) Heterozyklische kalium-kanal inhibitoren
MXPA03011722A (es) Derivados de piperidina utiles como moduladores de actividad de quimiocina.
HRP20050082A2 (en) 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
NO963706L (no) Benzenkondenserte heterosykliske derivater og deres anvendelse
NO20052023L (no) Kalsium aktivert K kanal apner med hoy konduktans
CY1108837T1 (el) ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5
DE60209806D1 (de) 2-amino-thiazolinderivate und ihre verwendung als hemmstoffe der induzierbaren no-synthase
NO961236L (no) Pyrrolodiazin-derivater som stabilisatorer for klorholdige polymerisater
TW355124B (en) Substituted pyrazolylpyrazole derivatives and their use as herbicides